Medtronic Cardiovascular
Clinical trials sponsored by Medtronic Cardiovascular, explained in plain language.
-
New TAVR care pathway shows promise in 1,127 patients
Disease control CompletedThis study looked at whether a special care plan could improve results for people getting a new heart valve through a less invasive procedure called TAVR. Over 1,100 patients with a narrowed heart valve (aortic stenosis) took part. The goal was to see if the new approach reduces …
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 24, 2026 08:31 UTC
-
New anchor device aims to secure aortic aneurysm repairs
Disease control CompletedThis registry tracked over 1,000 patients who received the Heli-FX EndoAnchor device during endovascular repair of aortic aneurysms. The device is designed to help hold the endograft in place and prevent leaks. Patients were followed for up to 5 years to see how safe and effectiv…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 24, 2026 08:20 UTC
-
New valve gives hope to heart patients too frail for surgery
Disease control CompletedThis study tested a new, less invasive heart valve (CoreValve) in 782 people with severe aortic stenosis who were too sick for open-heart surgery. The valve was placed through a tube in the leg, avoiding major surgery. The goal was to see if it could safely improve survival and r…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New heart valve shows promise in 638-Patient trial
Disease control CompletedThis study tested a new heart valve called Evolut PRO in 638 people with a narrowed or failing aortic valve. The valve was implanted using a less invasive procedure. The main goal was to see how many patients survived at 30 days and to check for any leaks around the new valve. Re…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC